ENDRA Life Sciences Inc. — Investor Relations & Filings

ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. The company's core technology is the Thermo-Acoustic Enhanced UltraSound (TAEUS®) platform, designed to enable clinicians to visualize tissue composition and function. The initial application of TAEUS is focused on the early detection and monitoring of liver disease by quantifying fat in the liver. This addresses the clinical need for assessing Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), which are often difficult to diagnose in their early stages. The TAEUS system aims to provide a safe, non-invasive, and cost-effective diagnostic tool that can be used at the point of patient care, offering an alternative to more expensive and less accessible imaging methods.